Leibniz Association Senate Board of Competition (SAW) Lung Microbiome Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Change in microbiome pattern in smokers after smoking cessation
Study Overview
Brief Summary
The trial aims to analyse changes in the microbiome of the lower airways after smoking cessation. Microbiome analyses (upper airway swabs, bronchoalveolar lavage, transbronchial brushing) are conducted in smokers before and 6 weeks after smoking cessation. Never smokers serve as a control group and undergo the same sampling procedures once.
Detailed Description
The trial aims to analyze changes in the microbiome of the lower airways after smoking cessation. Microbiome analyses (upper airway swabs, bronchoalveolar lavage, transbronchial brushing) are conducted in healthy (and willing to quit) smokers before and 6 weeks after smoking cessation. Never smokers serve as a control group and undergo the same sampling procedures once.
Demographic and clinical data of the study subjects are obtained, aiming for homogeneous groups. All personal data are encrypted according to the standard operating procedures of the study site. Pharyngeal and deep nasal swabs are taken.
To avoid contamination of the lower airways from the oropharynx through the bronchoscope, standardized procedures are established according to the German guidelines for bronchoscopy. Before bronchoscopy, the endoscope is flushed with sterile saline which is analyzed for 16S ribosomal RNA (rRNA) to control for residual contaminating bacterial desoxyribonucleic acid (DNA). A 300ml bronchoalveolar lavage with warm normal saline solution is taken from the middle lobe. Three covered and "microbiologically protected" bronchial brushings are obtained from the right upper lobe. This sterile brush is sealed in wax and pushed through the wax just before taking the brushing. All samples are immediately frozen and stored at -80°C until further analyses. For cultivations, samples are kept at 4°C and rapidly processed.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Cigarette consumption of at least five cigarettes per day
- •Caucasian ethnicity
Exclusion Criteria
- •Continous passive smoking exposure
- •Systemic steroid therapy during the previous month
- •Chronic lung disease (exception COPD stage Global Initiative on Lung Disease (GOLD) 0/I/II)
- •Diabetes mellitus
- •Pregnancy or breast feeding
- •active tuberculosis (currently or previously)
- •respiratory infection in the previous month
- •antibiotic therapy in the previous two months
- •immunosuppression
- •malignancy
- •interstitial lung disease
- •rheumatic disease with lung manifestation
- •member of a collaborative group of the project
Arms & Interventions
Smokers
Healthy caucasian smokers who are willing to quit smoking are investigated before cessation (Visit 1) and 6 weeks after cessation (Visit 2).
Intervention: Smoking cessation
Intervention: Smoking cessation (Behavioral)
Never-Smokers
Healthy caucasian volunteers who never smoked are investigated once only (Visit 1)
Outcomes
Primary Outcomes
Change in microbiome pattern in smokers after smoking cessation
Time Frame: 6 Weeks
Number of bacteria genera in the lung identified by 16S rRNA and bacterial culture
Secondary Outcomes
- Smoking cessation rates(6 months)
- Lung microbiome in never-smokers(0 days)
- Smoking cessation rates(6 weeks)